EDIT vs CRSP
EDIT and CRSP side by side — valuation & fundamentals (public data).
Key statistics
| Metric | EDITEDITAS MEDICINE, INC. | CRSPCRISPR THERAPEUTICS AG |
|---|---|---|
| Market cap | $409.29M | $4.97B |
| P/S | — | 1415.8x |
| Revenue growth (YoY) | — | -90.6% |
| Earnings growth (YoY) | — | -58.8% |
| EBIT margin | — | -18933.6% |
| ROE | — | -33.3% |
| ROIC | — | -32.6% |
| 1y total return | — | -15.9% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: EDIT frente a CRSP
| Métrica | EDIT | CRSP |
|---|---|---|
| Valor final | $1.9K | $36.5K |
| Retorno total | -80.8% | +264.9% |
| CAGR | -15.2% | +13.8% |
| Volatilidad | 84.3% | 63.9% |
| Sharpe | 0.16 | 0.45 |
| Sortino | 0.25 | 0.70 |
| Caída máxima | -98.9% | -85.1% |
Basado en 2522 días de negociación comunes, 2016-10-19 → 2026-10-30 · tasa libre de riesgo 4.16% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)